OpenVSafe by OpenVAERS
Search V-safe

5MJ-11305-92341

5 vaccinations 9 coded responses 38 check-ins 9 free-text entries 2 call cases
Sex
Female
Age at first dose
66+
ZIP prefix
545 / WI
Registered
2021-01-29
Relationship
Self
Race
Multiracial
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-20
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-29
    Registered in v-safe
  3. 2021-01-29
    Health check-in — day 7, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-02-03
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  5. 2021-02-12
    Health check-in — day 21, dose 1
    Feeling: Fair
    Adult check-in
  6. 2021-02-16
    Dose 2 — Pfizer-BioNTech
  7. 2021-02-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain, Redness, Swelling · Chills, Headache, Joint pains, Muscle or body aches · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  8. 2021-02-19
    Survey response — days 1–6 daily, dose 2
    MedDRA: No adverse event — Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-02-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Joint pains, Fatigue or tiredness
    Adult check-in
  10. 2021-02-21
    Survey response — days 1–6 daily, dose 2
    MedDRA: Eczema, Pre-existing disease — Feeling: Good · Rash, not including the immediate area around the injection site
    Free text: Usual excema acting out
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-02-22
    Survey response — days 1–6 daily, dose 2
    MedDRA: Eczema — Feeling: Good · Fatigue or tiredness
    Free text: Excema
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-02-23
    Survey response — day 7, dose 2
    MedDRA: Eczema, Pre-existing disease — Feeling: Good · Site: Itching · Rash, not including the immediate area around the injection site
    Free text: Excema way worse than it normally is at this one of the year. Afraid to use steroid ointments because of the CoVid Vacc.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-03-02
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-03-09
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-03-16
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-03-23
    Health check-in — day 35, dose 2
    Feeling: Fair
    Adult check-in
  17. 2021-03-31
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-05-18
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-08-17
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-09-16
    Dose 3 — Pfizer-BioNTech
  21. 2021-10-01
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  22. 2021-10-10
    Survey response — day 21, dose 3
    MedDRA: Arthralgia, Neck pain, Post procedural complication, Sacroiliitis, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Neck and shoulder pain. Exaserbation post rotator cuff repair. Sacroiliitis. · Healthcare visit (other): Depo-Medrol joint injections
    MedDRA releases: 2024-11 · check-in free text available
  23. 2021-10-10
    Report sent to call center — day 21, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  24. 2021-10-15
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  25. 2021-10-21
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  26. 2021-10-29
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  27. 2021-11-05
  28. 2021-12-16
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  29. 2022-03-17
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  30. 2022-04-01
    Dose 4 — Pfizer-BioNTech
  31. 2022-04-14
    Health check-in — day 7, dose 4
    Feeling: Fair · Site: Pain, Redness · Chills, Muscle or body aches, Diarrhea
    Adult check-in
  32. 2022-04-15
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  33. 2022-04-22
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  34. 2022-04-29
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  35. 2022-05-10
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  36. 2022-05-13
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  37. 2022-07-02
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  38. 2022-09-26
    Dose 5 — Pfizer-BioNTech
  39. 2022-10-02
    Survey response — 6 months, dose 4
    MedDRA: Oropharyngeal pain, Productive cough, Rhinorrhoea — Feeling: Fair
    Free text: Sore throat, runny nose, productive cough
    MedDRA releases: 2024-11 · check-in free text available
  40. 2022-10-15
    Survey response — day 14, dose 5
    MedDRA: Cough, Laboratory test abnormal, Sinusitis — Feeling: Poor · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Binax antigen test positive on 10/01 2022. Sinusitis, cough. Continued to test positive and symptomatic until 10/06/2022. Had been treated with five day course of molnupirivar. 10/10/2022 again tested positive continue to test positive, symptomat
    MedDRA releases: 2024-11 · check-in free text available
  41. 2022-10-15
    Report sent to call center — day 14, dose 5
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  42. 2022-10-17
    Survey response — day 21, dose 5
    MedDRA: Conjunctivitis, Nasal pruritus — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Itching nasal tissue, conjunctivitis,
    MedDRA releases: 2024-11 · check-in free text available
  43. 2022-10-17
  44. 2022-10-17
  45. 2022-10-25
    Health check-in — day 28, dose 5
    Feeling: Good
    Adult check-in
  46. 2022-11-02
    Health check-in — day 35, dose 5
    Feeling: Good
    Adult check-in
  47. 2022-11-07
    Health check-in — day 42, dose 5
    Feeling: Good
    Adult check-in
  48. 2022-12-27
    Survey response — 3 months, dose 5
    MedDRA: Arthritis, Asthma, Blood glucose increased — Feeling: Good · Be unable to do your normal daily activities
    Free text: Increased fasting glucose levels. Increased Asthma, increased Spondular Arthritis.
    MedDRA releases: 2024-11 · check-in free text available
  49. 2023-03-29
    Health check-in — 6 months, dose 5
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-20Pfizer-BioNTech
22021-02-16Pfizer-BioNTech
32021-09-16Pfizer-BioNTech No
42022-04-01Pfizer-BioNTech No
52022-09-26Pfizer-BioNTech No

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 4 — days 1–6 daily, dose 2

2021-02-19

Systemic reaction (other): None

2021-02-21

Systemic reaction (other): Usual excema acting out

2021-02-22

Systemic reaction (other): Excema

Release 4 — day 7, dose 2

2021-02-23

Systemic reaction (other): Excema way worse than it normally is at this one of the year. Afraid to use steroid ointments because of the CoVid Vacc.

Release 10 — day 21, dose 3

2021-10-10

Symptoms: Neck and shoulder pain. Exaserbation post rotator cuff repair. Sacroiliitis.
Healthcare visit (other): Depo-Medrol joint injections

Release 12 — 6 months, dose 4

2022-10-02

Symptoms: Sore throat, runny nose, productive cough

Release 12 — day 14, dose 5

2022-10-15

Symptoms: Binax antigen test positive on 10/01 2022. Sinusitis, cough. Continued to test positive and symptomatic until 10/06/2022. Had been treated with five day course of molnupirivar. 10/10/2022 again tested positive continue to test positive, symptomat cut off by CDC

Release 12 — day 21, dose 5

2022-10-17

Symptoms: Itching nasal tissue, conjunctivitis,

Release 12 — 3 months, dose 5

2022-12-27

Symptoms: Increased fasting glucose levels. Increased Asthma, increased Spondular Arthritis.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOUnevaluable event · · ✓
SDArthralgia · · ✓
SDArthritis · · ✓
SDAsthma · · ✓
SDBlood glucose increased · · ✓
SDConjunctivitis · · ✓
SDCough · · ✓
SDLaboratory test abnormal · · ✓
SDNasal pruritus · · ✓
SDNeck pain · · ✓
SDOropharyngeal pain · · ✓
SDPost procedural complication · · ✓
SDProductive cough · · ✓
SDRhinorrhoea · · ✓
SDSacroiliitis · · ✓
SDSinusitis · · ✓
SROEczema ✓ ✓ ✓
SRONo adverse event ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release